JointStem Emerging Drug Insight and Market Forecasts, 2019-2032: The World's First Stem Cell Therapy for Patients with Severe Knee OA

Source :: PR Newswire. December 7, 2023
Publication Year :: 2023
Abstract: DUBLIN, Dec. 7, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5680332/jointstem-emerging-drug-insight-and-market?utm_source=CI&utm_medium=PressRelease&utm_code=vpb4rr&utm_campaign=1917191+-+JointStem+Emerging+Drug+Insight+and+Market+Forecasts%2c+2019-2032%3a+The+World%27s+First+Stem+Cell+Therapy+for+Patients+with+Severe+Knee+OA&utm_exec=chdo54prd report has been added toResearchAndMarkets.com's offering. This report provides comprehensive insights about JointStem for osteoarthritis in the six major markets. A detailed [...]

Subjects :: Stem cells -- Reports -- Forecasts and trends -- Transplantation
Osteoarthritis -- Reports -- Forecasts and trends
Industrial research -- France -- Germany -- United Kingdom -- Ireland -- South Korea -- Canada -- Spain
Research and development
Market trend/market analysis
Business
News, opinion and commentary

Tools